Lectureship Awards

About Us_Lectureships_Banner

The International Association for the Study of Lung Cancer at its 2021 World Conference on Lung Cancer presented awards to clinicians and researchers who made significant contributions to the fight against lung cancer. The awards represent many major categories of lung cancer research, from tumor staging to tobacco control and smoking cessation.

2021 Lectureship Awards for Staging

The IASLC Lectureship Awards for Staging include:

  • Robert J. Ginsberg Lectureship Award for Surgery
  • Clifton F. Mountain Lectureship Award for Staging
  • Tsuguo Naruke Lectureship Award for Surgery

The award winners are selected by  the IASLC Staging and Prognostic Factors Committee chaired by Dr. Hisao Asamura, MD 

Image
Dr. James Huang

Dr. James Huang

Thoracic Surgeon, Memorial Sloan Kettering Cancer Center and Associate Professor of Cardiothoracic Surgery, Weil Cornell Medical College, New York
United States

Tsuguo Naruke Lectureship Award for Surgery

James Huang, MD is a thoracic surgeon on the faculty at Memorial Sloan Kettering Cancer Center and Associate Professor of Cardiothoracic Surgery at Weil Cornell Medical College in New York.  Dr. Huang completed his undergraduate studies at Harvard University and obtained his medical degree at the Columbia University College of Physicians and Surgeons. 

Following a general surgery residency at Brigham and Women’s Hospital in Boston, he completed his fellowship training in cardiothoracic surgery at Memorial Sloan Kettering and New York-Presbyterian Hospital and obtained a Master’s degree at the Mailman School of Public Health at Columbia.  Dr. Huang’s research interests include lung cancer, thymic malignancies, and outcomes in thoracic surgery.  He currently serves as Principal Investigator or Co-Principal Investigator in a number of clinical trials involving oligometastatic lung cancer, multifocal ground-glass opacities, multimodality therapy in thymic malignancies, and exercise in lung cancer survivors. 

Dr. Huang is a member of the Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer (IASLC) and serves as the Chair of the N-descriptors Subcommittee for Lung Cancer, and the Vice-Chair of the Thymic Malignancies Staging Committee.  He also has a strong interest in surgical education and serves as the Program Director for the Thoracic Surgery Fellowship Program, and the Associate Vice Chair for Education in the Department of Surgery at Memorial Sloan Kettering.  

Image
Dr. Ayten Kayi Cangir in front of a white background

Dr. Ayten K. Cangir

Professor of Thoracic Surgery at Ankara University, School of Medicine
Turkey

Clifton F. Mountain Lectureship Award for Staging

Dr. Ayten K. Cangir is a professor in the Thoracic Surgery Department at Ankara University, School of Medicine. She received her Medical Degree from Ankara University, School of Medicine, and her residency in Thoracic Surgery in the Department of Thoracic and Cardiovascular Surgery at Ankara University, School of Medicine.

Dr. Cangir's interest is in Lung Cancer Surgery, MPM Surgery, Staging Lung Cancer MPM and Thymic Malignancies, Esophageal resection and reconstruction, and Thoracic Outlet Syndrome. She is a member of the IASLC Lung Staging and Prognostic Factors Committee and the IASLC Thymic Malignancy Staging and Prognostic Factors Committee. 

Dr. Cangir has been an author on 56 articles in peer-reviewed International Journals. 

Image
Shun-ichi Watanabe

Dr. Shun-ichi Watanabe

Attending Thoracic Surgeon at the National Cancer Center Hospital
Japan

Robert J. Ginsberg Lectureship Award for Surgery 

Shun-ichi Watanabe, MD is  Chief of the Department of  Thoracic Surgery at the National Cancer Center Hospital in Toyko Japan. Dr. Watanabe attended Medical school at Kanazawa University School of Medicine from 1984 -1990 and was awarded his Doctor of Medical Science degree from the post-graduate School of Medicine, Kanazawa University. 

Dr. Watanabe received his training in surgery from Kanazawa University School of Medicine as well as training in Europe at the Department of Thoracic Surgery, Royal Brompton Hospital, in London, UK. He has been an attending Surgeon in the Department of Thoracic Surgery at the National Cancer Center Hospital since April 2002. 

Dr. Watanabe is also a chair of the Lung Cancer Surgical Study Group, Japan Clinical Oncology Group (JCOG) since January 2015. 

2021 Lectureship Nominating Committee Awards

The IASLC Lectureship Awards for the Nominating Committee include:

  • Daniel C. Ihde Lectureship Award for Medical Oncology 
  • Heine H. Hansen Lectureship Award for Small Cell Lung Cancer 

The award winners are selected by the IASLC Nominating Committee chaired by Dr. Giorgio Scagliotti 

Image
Dr. Trudy Oliver in a white Coat smiling

Dr. Trudy Oliver

Associate Professor of Oncological Sciences, University of Utah; Huntsman Cancer Institute Endowed Chair in Cancer Research, Salt Lake City, Utah
United States

Heine H. Hansen Lectureship Award for Small Cell Lung Cancer

Trudy G. Oliver, Ph.D. is an Associate Professor in the Department of Oncological Sciences at the University of Utah and a Huntsman Cancer Institute (HCI) Endowed Chair in Cancer Research in Salt Lake City, Utah. She received her PhD from Duke University in Pharmacology and Cancer Biology, and her postdoctoral fellowship at the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT). Dr. Oliver is currently co-leader of the Cell Response and Regulation (CRR) program and co-leader of the Lung Cancer Center at HCI. Dr. Oliver has received many awards including from the National Science Foundation, Damon Runyon Cancer Research Foundation, the V Foundation for Cancer Research, American Cancer Society, American Lung Association, and was honored with a William C. Rippe Award for Distinguished Research in Lung Cancer from the Lung Cancer Research Foundation.

Dr. Oliver's research is devoted to understanding mechanisms of lung cancer biology with the goal of identifying novel therapeutic targets to improve patient outcome. Her laboratory has developed multiple, novel mouse models of squamous and small cell lung cancer (SCLC). Using these systems, her laboratory discovered that the MYC oncogene drives unique molecular subtypes of SCLC, and that SCLC subtypes demonstrate plasticity in mouse and human tumors. Dr. Oliver’s work has identified multiple therapeutic vulnerabilities for molecular subsets of SCLC, including the observation that SCLC subtypes are metabolically distinct with MYC-high SCLC uniquely dependent on arginine. Dr. Oliver serves on the Scientific Advisory Board for Lung Cancer Research Foundation and is a co-PI of the Coordinating Center for the National Cancer Institute SCLC Research Consortium.

Dr. Oliver's trainees have received a number of prestigious awards. These include the Susan Cooper Jones Postdoc of the Year Award, the James W. Prahl Memorial Graduate Student of the Year award, an NIH NCI F99/K00 Predoctoral to Postdoctoral Fellow Transition Award, and the School of Medicine and School of Engineering Undergraduate of the Year award. In addition, Oliver lab trainees have won a number of travel awards including to Keystone Symposia, the John Weis Memorial Graduate Student Award, and selection as a recipient to the 68th Annual Lindau Nobel Laureate meeting in Germany.

Image
Fabrice Barlesi

Fabrice Barlesi

Chief Medical Officer & Head of Clinical Research, Gustave Roussy, Villejuif
France

Daniel C. Ihde Lectureship Award for Medical Oncology

A specialist in lung cancer, precision medicine and cancer immunology, Professor Barlesi is one of the major players in research on innovative cancer therapies.

He is contributing his expertise to the construction of Gustave Roussy's new 2021-2026 establishment project and will ensure its deployment in the medical policy that he will be conducting.

Prof. Barlesi is 50 years old and a professor of medicine at the University of Aix-Marseille. He holds a doctorate in science and management, methods of analysis of health systems and a master's degree in general hospital management from ESSEC.

Prof. Barlesi co-founded the French immunology cluster Marseille Immunopole whose mission is to bring together the immunology expertise of the Aix-Marseille metropolis. He has also created the Marseille Centre for Early Tests in Cancer (CLIP2).

Prof. Barlesi is the author and co-author of nearly 400 publications in international journals and specialized books. In 2019, he will be included in the list of the world's most influential researchers (Highly cited researchers of the Web of Science Group).

2021 Lectureship Awards for Tobacco Control and Smoking Cessation

The 2021 IASLC Lectureship Awards for Tobacco Control and Smoking Cessation include: 

  • IASLC Lectureship Awards for Tobacco Control and Smoking Cessation 

The award winners are selected by the IASLC Tobacco Control and Smoking Cessation Committee Chaired by Dr. Matthew Steliga

Image
Dr. Graham Warren in a white coat standing infront of a staircase

Dr. Graham Warren

Radiation Oncologist, Vice Chairman for Research, Department of Radiation Oncology; Mary Gilbreth Endowed Chair of Clinical Oncology, Hollings Cancer Center, Medical University of South Carolina
United States

IASLC Lectureship Award for Tobacco Control and Smoking Cessation

Graham Warren, MD, PhD, is a Board-Certified Radiation Oncologist, Vice Chairman for Research in the Department of Radiation Oncology, and Mary Gilbreth Endowed Chair of Clinical Oncology in Hollings Cancer Center at the Medical University of South Carolina (MUSC). His primary clinical emphasis is in the treatment of gastrointestinal and thoracic malignancies and has served as the Medical Director for Tobacco at MUSC and Roswell Park Cancer Institute.  He works with several local, regional, national, and international organizations to increase access to evidence-based tobacco cessation support for cancer patients.  He is an Expert Advisor for the Canadian Partnership Against Cancer (CPAC) and works with the National Institutes of Health to implement strategies to address tobacco use across cancer care and has served as a chair and/or member on tobacco or prevention committees for the American Society for Clinical Oncology (ASCO), American Association for Cancer Research (AACR), International Association for the Study of Lung Cancer (IASLC), Society for Research on Nicotine and Tobacco (SRNT), National Lung Cancer Roundtable, National Cancer Institute (NCI), and the Alliance for Clinical Trials in Oncology Cooperative Group.  He was a contributor for the 2014 Surgeon General’s Report on Tobacco providing the foundational work demonstrating that smoking by cancer patients and survivors causes adverse cancer treatment outcomes.  He was a contributor for the 2020 Surgeon General’s Report demonstrating that smoking cessation after a cancer diagnosis improves survival in cancer patients.  His work has been used to develop tobacco treatment programs for cancer patients at the institutional, regional, statewide, national, and international level including cessation initiatives across Canadian Provinces and Territories and for the NCI Cancer Center Cessation Initiative (C3I) P30 supplement distributed across NCI Designated Cancer Centers.  His primary research interest is in evaluating the biologic, clinical, behavioral, and economic effects of tobacco on cancer treatment outcomes including identifying critical biologic targets to improve therapeutic outcomes in cancer patients exposed to tobacco, and optimizing behavioral and clinical methods to optimize data collection that can be used for clinical decision making and research.

2021 Lectureship Award for Radiation Oncology 

The 2021 IASLC Lectureship Award for Radiation Technology include: 

  • James D. Cox Lectureship Award for Radiation Oncology 

The award winners lectureship award for radiation oncology is nominated by the Advanced Radiation Technology Committee chaired by Dr. Corinne Fairve-Finn. 

Image
Cecile Le Pechoux Smiling in a white medical coat

Dr. Cecile Le Pechoux

Senior Radiation Oncologist at Gustave Roussy Comprehensive Cancer Center
France

James D. Cox Lectureship Award for Radiation Oncology

Cécile Le Péchoux, M.D. is the Senior Radiation Oncologist at Gustave Roussy Comprehensive Cancer Center in Villejuif France, has been involved in the Thoracic Diseases Unit and Sarcoma Unit of the Radiation Oncology department. Her areas of interest are combined modality treatment in both non-small cell lung cancer and small-cell lung cancer, thymoma, sarcomas, multidisciplinary approaches in cancer treatment including those with immunotherapy, high precision radiotherapy (stereotactic ablative radiotherapy, intensity-modulated radiotherapy). She has contributed to more than 200 peer-reviewed publications. She has been participating actively to EORTC Radiation Oncology Group and Lung Group, and IFCT (French-speaking Thoracic Oncology Group). She has been involved in the scientific committee of the IASLC 2013-2015. She has participated to several prospective studies both in the field of lung cancer and sarcoma; she has been the coordinating investigator of Lung ART, a phase III trial in stage IIIN2 NSCLC.

2021 Lectureship Nurses and Allied Health Professionals Award Winners

The 2021 Lectureship Awards for Nurses and Allied Health Professionals include: 

  • IASLC Lectureship Award for Nurses and Allied Health Professionals 
  • James D. Cox Lectureship Award for Radiation Oncology 

The award winners are selected by the IASLC Nurses and Allied Health Professionals Committee Chaired by Dr. Melissa Culligan 

Image
Pippa Labuc wearing a blue shirt and glasses with short hair. Smiling in front of a grey background

Pippa Labuc

Occupational Therapist, Specializing in Thoracic Oncology, Guy’s and St Thomas’ NHS foundation
United Kingdom

IASLC Lectureship Award for Nurses and Allied Health Professionals

Pippa Labuc is an Occupational Therapist who has worked within the cancer and palliative care field for the past 9 years, specializing in thoracic oncology at Guy’s and St Thomas’ NHS foundation trust in the UK and more recently Cabrini Health Australia.

She has a passion for providing holistic patient-centered care, focusing on rehabilitation and non-pharmacological symptom management throughout the cancer pathway.

She has been an active member of IASLC since 2015, acting as chair to the Nursing and Allied Health committee from 2017-2019.

2021 Lectureship Award for Pathology Committee

The Lectureship Award for the Pathology Committee is:

  • Fred R. Hirsch Lectureship Award for Translational Research 

In its innagural year the award winner was selected by the Pathology Committee chaired by Dr. Keith Kerr. 

Image